Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03898570 · ClinicalTrials.gov registry record
Distributed Registry
A clinical trial of Cardiovascular Diseases and Peripheral Arterial Disease, sponsored by Stanford University.
- Completed
- Registry status
- 100
- Enrollment target
- 2
- Study locations
NCT03898570: Completed study of Cardiovascular Diseases and Peripheral Arterial Disease, sponsored by Stanford University.
NCT03898570 is a study of Cardiovascular Diseases and Peripheral Arterial Disease that has completed, run by Stanford University. The registered enrollment target is 100 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03898570, a study of Cardiovascular Diseases and Peripheral Arterial Disease, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to test if a patient can be directly connected to a quality assurance (QA) database, traditionally known as a registry. Patient-reported outcomes (PRO) data will be entered into the database directly from a patient's mobile phone from their index procedure for 12 months. The investigators hope this study to be a "proof of concept" for such a distributed registry and evaluate 1) consistency of data acquisition, 2) engagement of patients, 3) overall value of patient-reported outcomes to enhance long term follow up.
Primary Outcome
PROs are any report of the status of a patient's health condition that comes directly from the patient, without interpretation of the patient's response by a clinician or anyone else
Conditions Studied
Interventions
- BEHAVIORAL Patient reported outcomes
Study Locations (2)
California
- Palo Alto Veterans Hospital - Palo Alto
- Stanford - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2021-03-01 |
What the finished NCT03898570 record still lists
NCT03898570 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).
The record links to 10 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Patient reported outcomes is the first listed.
NCT03898570 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03898570 about?
NCT03898570 is a clinical study titled "Distributed Registry". The purpose of this study is to test if a patient can be directly connected to a quality assurance (QA) database, traditionally known as a registry. Patient-reported outcomes (PRO) data will be entered into the database directly from a patient's mobile phone from their index procedure for 12 months....
What is the current status of trial NCT03898570?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2019-04-01. Estimated completion is 2021-03-01.
What conditions does trial NCT03898570 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Peripheral Arterial Disease, Atherosclerosis, Vascular Diseases, Peripheral Vascular Diseases.
What interventions are being tested in trial NCT03898570?
The interventions under investigation include: Patient reported outcomes (BEHAVIORAL).
Who is sponsoring clinical trial NCT03898570?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03898570 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03898570's enrollment target sits among peer trials
100 194th of 300 higher than 101 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI